Identification of three ADA2 deficiency families with novel  mutations by unknown
POSTER PRESENTATION Open Access
Identification of three ADA2 deficiency families
with novel CECR1 mutations
G Sarrabay*, A Insalaco, F Uettwiller, N Tieulié, P Quartier-dit-maire, J Melki, I Touitou
From 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases
Dresden, Germany. 30 September - 3 October 2015
Introduction
Adenosine desaminase 2 deficiency (DADA2) is a rare
monogenic autoinflammatory disease, presenting with
systemic inflammation, vascular pathology with possible
strokes, and mild immunodeficiency. Recently, the
CECR1 gene was found to be responsible for this disease
with an autosomal recessive inheritance.
Objective
We report new mutations identified in 3 families
referred to our laboratories for genetic diagnosis.
Patients and methods
In family 1 (French), the proband, a 9 year-old girl,
exhibited fever, pseudo periarteritis nodosa (PAN) and
several strokes. Her 7-year old sister presented with
fever, anemia and neurological impairments (headaches,
drowsiness and third cranial nerve palsy). In family 2
(Italian), the index-case had recurrent fever, arthromyal-
gia, and livedo reticularis of trunk and limbs. In family 3
(Tunisian), consanguineous brother and sister exhibited
pleiomorphic vascularitis features (PAN, livedo, renal
microaneurysms) with inflammation and anemia. Par-
ents in all families were asymptomatic.
Using double-strand Sanger sequencing (ABI3130x, Life
Technologies), we searched for point mutations in the
CECR1 coding regions. Quantitative polymerase chain
reaction (qPCR) analysis was subsequently performed
(LightCycler, Roche) when only one point mutation was
identified (family 1).
Results
The two sisters of family 1 harbored two compound
heterozygous mutations: p.Tyr453Cys (published) and
deletion of the entire exon 7 (novel). We identified a
new variant in family 2: p.Arg49Glyfs*4 (c.144del), and
p.Thr360Ala, a published mutation. In family 3, we
found a homozygous substitution, p.Gly25Cys in both
siblings. This new variant was predicted to be benign by
different algorithms but was absent from general data-
bases (allele frequency <10-4 in ExAC). Exome analysis
was performed and this variant was the only one to be
retained after the various filters. However, this variant
remains controversial until extensive family investigation
is performed. We confirmed that each parental allele
carried a mutation in the 3 families.
Conclusion
We report here 3 new variants in the CECR1 gene.
Since DADA2 is an auto-inflammatory disease with ori-
ginal neurological involvement, CECR1 testing should
be widely performed in patients with such a phenotype.
Both point mutations and deletions have to be searched.
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